Now introducing the Lindus Health Roundup newsletter!

We're excited to launch our LinkedIn newsletter, where we'll provide updates on all things Lindus Health on a quarterly basis - covering study updates, content, and more to other news in the life sciences industry.

We kicked off summer by bringing everyone together for our annual away day at the beautiful Fanhams Hall in Ware, England! We had the best time playing boardgames, competing in lawn games, and doing other team-building activities with the entire company.

In addition, our team grew by 5 over the last quarter, expanding in our Clinical Operations, Product, and Operations teams! So far this year we've brought on a total of 15 new hires, and we're still growing. 

New Study Spotlight

Aktiia

This fully remote study will assess the user experience of and monitor blood pressure changes in Aktiia 's non-invasive wearable device in 7,500 participants. Read our announcement.

Cleo Diagnostics

This trial will see up to 500 participants in the US to test the accuracy of Cleo Diagnostics ' blood test in detecting ovarian cancer. Lindus will also support their 510(k) application. Read the full release.

Conferences

This month and last, we had the privilege of showcasing our work at the ATS 2024 International Conference, the 2024 CDISC + TMF Europe Interchange, and the ADA 84th Scientific Sessions.

ATS 2024

Our VP of Medical, Dr. Luke Twelves, led a poster session discussion with Accurx highlighting results and trial execution tactics utilized for our study that assessed the effectiveness of personalized text message reminders on inhaler adherence.

2024 CDISC + TMF Europe Interchange

Our Product team gave two presentations here on data-driven approaches for enhancing clinical trial processes, including AI mapping to predict trial outcomes and pairing USDM and ICH M11 for optimizing protocol design. 

Other Lindus Health Updates

Lindus Health and the University of Oxford published diversity study

We conducted a study with the University of Oxford looking at perceptions from both researchers and the general population about clinical trial participation among underrepresented populations, including barriers to engaging in research, factors that would boost likelihood to join a study, and more.

Read the full report.

Lindus Health and Tasso, Inc. launched collaboration for remote blood collection in clinical trials

We've partnered with Tasso, the leading provider of patient-centric, clinical grade blood collection solutions, to provide their virtually painless blood collection technology for sponsors aiming to facilitate simple, cost-effective remote blood collection their during clinical trials. This incorporation of Tasso's technology can reduce patient burden by mitigating logistical factors such as travel to physical sites and long study visits involving blood draws.

Read the full announcement.

New Content

Medical Device Research and Innovations Today

We conducted a comprehensive market analysis of medical device research over the last few years, looking closely at demographics of medical device sponsors and therapeutic areas of focus. Our insights can be found in our latest white paper.

Strategies for Successful Consumer Health Research

Based on our deep expertise in consumer health research, we've developed a guide covering unique trial execution, recruitment, and retention strategies that can accelerate study timelines and promote patient centricity.

As we wrap up activities for the first half of 2024, we thank you for your engagement and support and we can't wait to see what the rest of this year has in store!